Leucine supplementation modulates fuel substrates utilization and glucose metabolism in previously obese mice

Obesity

Volumn 22, Issue 3, 2014, Pages 713-720

  Binder, Elke ^a   Bermúdez Silva, Francisco Javier ^a,b   Elie, Melissa ^a   Leste Lasserre, Thierry ^a   Belluomo, Ilaria ^a   Clark, Samantha ^a   Duchampt, Adeline ^c,d,e   Mithieux, Gilles ^c,d,e   Cota, Daniela ^a  

^a INSTITUT FRANÇOIS MAGENDIE   (France)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^c INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DRINKING WATER; FATTY ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LEUCINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BROWN ADIPOSE TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG SENSITIVITY; ENERGY BALANCE; ENERGY EXPENDITURE; EPIDIDYMIS FAT; FAT MASS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FOOD INTAKE; GENE EXPRESSION; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LEPTIN SENSITIVITY; MALE; MOUSE; MUSCLE TISSUE; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; RESPIRATORY QUOTIENT; WEIGHT MAINTENANCE; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ANIMALIA; MUS;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; CALORIMETRY, INDIRECT; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; ENERGY METABOLISM; GLUCONEOGENESIS; GLUCOSE TOLERANCE TEST; INSULIN; INTESTINES; LEPTIN; LEUCINE; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; WEIGHT LOSS;

EID: 84895821132     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20578     Document Type: Article

References (40)

1. Popkin BM,. Understanding global nutrition dynamics as a step towards controlling cancer incidence. Nat Rev Cancer 2007; 7: 61-67.
2. Westerterp-Plantenga MS, Nieuwenhuizen A, Tome D, Soenen S, Westerterp KR,. Dietary protein, weight loss, and weight maintenance. Annu Rev Nutr 2009; 29: 21-41.
3. Laviano A, Muscaritoli M, Cascino A, et al. Branched-chain amino acids: the best compromise to achieve anabolism? Curr Opin Clin Nutr Metab Care 2005; 8: 408-414.
4. Proud CG,. Amino acids and mTOR signalling in anabolic function. Biochem Soc Trans 2007; 35: 1187-1190.
5. Weitzel LR, Sandoval PA, Mayles WJ, Wischmeyer PE,. Performance-enhancing sports supplements: role in critical care. Crit Care Med 2009; 37: S400-S409.
6. Cota D, Proulx K, Smith KA, et al. Hypothalamic mTOR signaling regulates food intake. Science 2006; 312: 927-930.
7. Blouet C, Jo YH, Li X, Schwartz GJ,. Mediobasal hypothalamic leucine sensing regulates food intake through activation of a hypothalamus-brainstem circuit. J Neurosci 2009; 29: 8302-8311.
8. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH,. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007; 56: 1647-1654.
9. Macotela Y, Emanuelli B, Bang AM, et al. Dietary leucine-An environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One 2011; 6: e21187.
10. Noguchi Y, Nishikata N, Shikata N, et al. Ketogenic essential amino acids modulate lipid synthetic pathways and prevent hepatic steatosis in mice. PLoS One 2010; 5: e12057.
11. Freudenberg A, Petzke KJ, Klaus S,. Comparison of high-protein diets and leucine supplementation in the prevention of metabolic syndrome and related disorders in mice. J Nutr Biochem 2012; 23: 1524-1530.
12. Felig P, Marliss E, Cahill GF Jr,. Plasma amino acid levels and insulin secretion in obesity. N Engl J Med 1969; 281: 811-816.
13. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009; 9: 311-326.
14. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH,. Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 2010; 5: e15234.
15. Adams SH,. Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state. Adv Nutr 2011; 2: 445-456.
16. She P, Van Horn C, Reid T, Hutson SM, Cooney RN, Lynch CJ,. Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism. Am J Physiol Endocrinol Metab 2007; 293: E1552-E1563.
17. Laferrere B, Reilly D, Arias S, et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 2011; 3: 80re2.
18. Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med 2011; 17: 448-453.
19. Lackey DE, Lynch CJ, Olson KC, et al. Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity. Am J Physiol Endocrinol Metab 2013; 304: E1175-E1187.
20. Cardinal P, Bellocchio L, Clark S, et al. Hypothalamic CB1 cannabinoid receptors regulate energy balance in mice. Endocrinology 2012; 153: 4136-4143.
21. Pitman JL, Bonnet DJ, Curtiss LK, Gekakis N,. Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites. J Lipid Res 2011; 52: 1775-1786.
22. Rajas F, Croset M, Zitoun C, Montano S, Mithieux G,. Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes 2000; 49: 1165-1168.
23. Tuduri E, Marroqui L, Soriano S, et al. Inhibitory effects of leptin on pancreatic alpha-cell function. Diabetes 2009; 58: 1616-1624.
24. Favereaux A, Thoumine O, Bouali-Benazzouz R, et al. Bidirectional integrative regulation of Cav1.2 calcium channel by microRNA miR-103: role in pain. EMBO J 2011; 30: 3830-3841.
25. Sampath H, Ntambi JM,. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-alpha: independent and interactive roles in the regulation of lipid metabolism. Curr Opin Clin Nutr Metab Care 2006; 9: 84-88.
26. Lenhard JM,. Lipogenic enzymes as therapeutic targets for obesity and diabetes. Curr Pharm Des 2011; 17: 325-331.
27. Kuhajda FP, Ronnett GV,. Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity. Curr Opin Investig Drugs 2007; 8: 312-317.
28. Lefebvre P, Chinetti G, Fruchart JC, Staels B,. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 2006; 116: 571-580.
29. Mithieux G, Andreelli F, Magnan C,. Intestinal gluconeogenesis: key signal of central control of energy and glucose homeostasis. Curr Opin Clin Nutr Metab Care 2009; 12: 419-423.
30. Myers MG Jr, Leibel RL, Seeley RJ, Schwartz MW,. Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010; 21: 643-651.
31. Donato J Jr, Pedrosa RG, Cruzat VF, Pires IS, Tirapegui J,. Effects of leucine supplementation on the body composition and protein status of rats submitted to food restriction. Nutrition 2006; 22: 520-527.
32. Zemel MB, Bruckbauer A,. Effects of a leucine and pyridoxine-containing nutraceutical on fat oxidation, and oxidative and inflammatory stress in overweight and obese subjects. Nutrients 2012; 4: 529-541.
33. Bruckbauer A, Zemel MB, Thorpe T, et al. Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond) 2012; 9: 77.
34. Westphal CH, Dipp MA, Guarente L,. A therapeutic role for sirtuins in diseases of aging? Trends Biochem Sci 2007;32: 555-560.
35. Kozak LP, Anunciado-Koza R,. UCP1: Its involvement and utility in obesity. Int J Obes (Lond) 2008; 32 (Suppl 7): S32-S38.
36. Nairizi A, She P, Vary TC, Lynch CJ,. Leucine supplementation of drinking water does not alter susceptibility to diet-induced obesity in mice. J Nutr 2009; 139: 715-719.
37. Floyd JC Jr, Fajans SS, Knopf RF, Conn JW,. Evidence that insulin release is the mechanism for experimentally induced leucine hypoglycemia in man. J Clin Invest 1963; 42: 1714-1719.
38. Leclercq-Meyer V, Marchand J, Woussen-Colle MC, Giroix MH, Malaisse WJ,. Multiple effects of leucine on glucagon, insulin, and somatostatin secretion from the perfused rat pancreas. Endocrinology 1985; 116: 1168-1174.
39. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002; 415: 339-343.
40. Blouet C, Schwartz GJ,. Brainstem nutrient sensing in the nucleus of the solitary tract inhibits feeding. Cell Metab 2012; 16: 579-587.